Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q1 2026 Earnings

5MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.68

-0.63

-0.59

-0.54

Details

Expected EPS

-0.605928

Actual EPS

-0.59

Surprise EPS

0.02

Surprise Percent

+2.63%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -0.59 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.